“A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 465 Patients 2 Years and Older with Impetigo” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s104. doi:10.25251/skin.1.supp.103.